Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
1 Mega-Cap Stock on Our Watchlist and 2 We Avoid
1 Mega-Cap Stock on Our Watchlist and 2 We Avoid
1 Mega-Cap Stock on Our Watchlist and 2 We Avoid
Adam Hejl
Wed, February 18, 2026 at 1:32 PM GMT+9 3 min read
In this article:
ORCL
-3.85%
ABBV
+0.59%
JPM
+1.51%
Megacap stocks dominate their sectors and their actions influence economies worldwide. The flip side though is that their sheer size means they have less room for explosive growth as scale works against them.
This dynamic can trouble even the most skilled investors, but luckily for you, we started StockStory to help you navigate these trade-offs and uncover exceptional companies that break the mold. That said, here is one industry titan that still has big upside potential and two that could be stalling.
Two Mega-Cap Stocks to Sell:
JPMorgan Chase (JPM)
Market Cap: $828.3 billion
Tracing its roots back to 1799 when its earliest predecessor was founded by Aaron Burr, JPMorgan Chase (NYSE:JPM) is a leading financial services company offering investment banking, consumer banking, commercial banking, and asset management services globally.
Why Are We Hesitant About JPM?
JPMorgan Chase is trading at $307.19 per share, or 2.2x forward P/B. Dive into our free research report to see why there are better opportunities than JPM.
Oracle (ORCL)
Market Cap: $442.5 billion
Starting as a database company in 1977 and now powering mission-critical systems across the globe, Oracle (NYSE:ORCL) provides enterprise software and hardware products and services that help businesses manage their information technology needs.
Why Do We Avoid ORCL?
At $153.40 per share, Oracle trades at 6.2x forward price-to-sales. Check out our free in-depth research report to learn more about why ORCL doesn’t pass our bar.
One Mega-Cap Stock to Watch:
AbbVie (ABBV)
Market Cap: $411.6 billion
Born from a 2013 spinoff of Abbott Laboratories’ pharmaceutical business, AbbVie (NYSE:ABBV) is a biopharmaceutical company that develops and markets medications for autoimmune diseases, cancer, neurological disorders, and other complex health conditions.
Why Could ABBV Be a Winner?
AbbVie’s stock price of $232.50 implies a valuation ratio of 15.9x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.
The names generating the next wave of massive growth are right here in our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
Terms and Privacy Policy
Privacy Dashboard
More Info